These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 14526190)
1. Mechanisms of neuronal cell death in Huntington's disease. Sawa A; Tomoda T; Bae BI Cytogenet Genome Res; 2003; 100(1-4):287-95. PubMed ID: 14526190 [TBL] [Abstract][Full Text] [Related]
2. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease. Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303 [TBL] [Abstract][Full Text] [Related]
3. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958 [TBL] [Abstract][Full Text] [Related]
4. Towards a transgenic model of Huntington's disease in a non-human primate. Yang SH; Cheng PH; Banta H; Piotrowska-Nitsche K; Yang JJ; Cheng EC; Snyder B; Larkin K; Liu J; Orkin J; Fang ZH; Smith Y; Bachevalier J; Zola SM; Li SH; Li XJ; Chan AW Nature; 2008 Jun; 453(7197):921-4. PubMed ID: 18488016 [TBL] [Abstract][Full Text] [Related]
5. Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. Wellington CL; Ellerby LM; Gutekunst CA; Rogers D; Warby S; Graham RK; Loubser O; van Raamsdonk J; Singaraja R; Yang YZ; Gafni J; Bredesen D; Hersch SM; Leavitt BR; Roy S; Nicholson DW; Hayden MR J Neurosci; 2002 Sep; 22(18):7862-72. PubMed ID: 12223539 [TBL] [Abstract][Full Text] [Related]
6. Genetics and neuropathology of Huntington's disease. Reiner A; Dragatsis I; Dietrich P Int Rev Neurobiol; 2011; 98():325-72. PubMed ID: 21907094 [TBL] [Abstract][Full Text] [Related]
7. Pathogenic mechanisms in Huntington's disease. Jones L; Hughes A Int Rev Neurobiol; 2011; 98():373-418. PubMed ID: 21907095 [TBL] [Abstract][Full Text] [Related]
8. The use of transgenic and knock-in mice to study Huntington's disease. Hickey MA; Chesselet MF Cytogenet Genome Res; 2003; 100(1-4):276-86. PubMed ID: 14526189 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms for neuronal cell death and dysfunction in Huntington's disease: pathological cross-talk between the nucleus and the mitochondria? Sawa A J Mol Med (Berl); 2001 Jul; 79(7):375-81. PubMed ID: 11466559 [TBL] [Abstract][Full Text] [Related]
10. Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features. Han I; You Y; Kordower JH; Brady ST; Morfini GA J Neurochem; 2010 Jun; 113(5):1073-91. PubMed ID: 20236390 [TBL] [Abstract][Full Text] [Related]
11. The early cellular pathology of Huntington's disease. Li XJ Mol Neurobiol; 1999; 20(2-3):111-24. PubMed ID: 10966117 [TBL] [Abstract][Full Text] [Related]
13. Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease. Wyttenbach A; Swartz J; Kita H; Thykjaer T; Carmichael J; Bradley J; Brown R; Maxwell M; Schapira A; Orntoft TF; Kato K; Rubinsztein DC Hum Mol Genet; 2001 Aug; 10(17):1829-45. PubMed ID: 11532992 [TBL] [Abstract][Full Text] [Related]
14. Effects on murine behavior and lifespan of selectively decreasing expression of mutant huntingtin allele by supt4h knockdown. Cheng HM; Chern Y; Chen IH; Liu CR; Li SH; Chun SJ; Rigo F; Bennett CF; Deng N; Feng Y; Lin CS; Yan YT; Cohen SN; Cheng TH PLoS Genet; 2015 Mar; 11(3):e1005043. PubMed ID: 25760041 [TBL] [Abstract][Full Text] [Related]
15. Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice. Bradford J; Shin JY; Roberts M; Wang CE; Sheng G; Li S; Li XJ J Biol Chem; 2010 Apr; 285(14):10653-61. PubMed ID: 20145253 [TBL] [Abstract][Full Text] [Related]
16. Lentiviral-mediated delivery of mutant huntingtin in the striatum of rats induces a selective neuropathology modulated by polyglutamine repeat size, huntingtin expression levels, and protein length. de Almeida LP; Ross CA; Zala D; Aebischer P; Déglon N J Neurosci; 2002 May; 22(9):3473-83. PubMed ID: 11978824 [TBL] [Abstract][Full Text] [Related]
17. Adenovirus vector-based in vitro neuronal cell model for Huntington's disease with human disease-like differential aggregation and degeneration. Dong X; Zong S; Witting A; Lindenberg KS; Kochanek S; Huang B J Gene Med; 2012 Jul; 14(7):468-81. PubMed ID: 22700462 [TBL] [Abstract][Full Text] [Related]
18. Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice. Wang J; Wang CE; Orr A; Tydlacka S; Li SH; Li XJ J Cell Biol; 2008 Mar; 180(6):1177-89. PubMed ID: 18362179 [TBL] [Abstract][Full Text] [Related]
19. Aggregation in Huntington's disease: insights through modelling. Cajavec B; Bernard S; Herzel H Genome Inform; 2005; 16(1):262-71. PubMed ID: 16362929 [TBL] [Abstract][Full Text] [Related]
20. Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion. Huang B; Schiefer J; Sass C; Kosinski CM; Kochanek S J Gene Med; 2008 Mar; 10(3):269-79. PubMed ID: 18067195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]